ReviewFrontiers in immunology2023

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy.

Susanna Esposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.